ENTITY
Jiangsu Hengrui Medicine

Jiangsu Hengrui Medicine (600276 CH)

271
Analysis
Health CareChina
Jiangsu Hengrui Medicine Co., Ltd. develops, manufactures, and markets a variety of medicines and medicine packing materials. The Company's products include anti-tumor medicines, pain-killers, anti-infection medicines, aluminum foil, and other related products.
more
21 Oct 2021 09:05

Pre-IPO Beijing Mabworks Biotech - MIL62 Alone Cannot Save the Situation

This article mainly analyzed Mabworks Biotech in terms of the important clinical-stage drug candidates (MIL62, MIL93, MBS301, MIL97, MIL95, MIL86,...

Logo
288 Views
Share
19 Oct 2021 08:51

Shenzhen Mindray Bio-Medical Electronics (300760.CH) - The Logic Behind Optimism

The article analyzed Mindray in terms of the core businesses, the 2021H1 performance, the impact of centralized procurement, the Hytest deal, the...

Logo
244 Views
Share
18 Oct 2021 08:51

China Healthcare Weekly (Oct15)-Growth Hormone VBP, Biotech's Business Model,Innovative Drug Outlook

The article analyzed the VBP on recombinant human growth hormone, the difference in business model of big pharma/biopharma and biotech, and the...

Logo
212 Views
Share
bullishRemegen
12 Oct 2021 09:04

Remegen Co Ltd (9995.HK) - Insights About the First Round Enquiry by Shanghai Stock Exchange

This article mainly analyzed RemeGen in terms of its reply to Shanghai Stock Exchange’s first round enquiry,  the core products, the pipeline, the...

Logo
252 Views
Share
10 Oct 2021 09:07

China Healthcare Weekly (Oct.8)-Summary of Concerns on Pharma Companies, VBP on TCM, Q4 PD-1 Bidding

The article analyzed thoughts and concerns on domestic pharmaceutical companies, VBP on Chinese patent medicine and foreign companies' preparation...

Logo
249 Views
Share
x